4.5 Article

Effects of ApoE4 and maternal history of dementia on hippocampal atrophy

Journal

NEUROBIOLOGY OF AGING
Volume 33, Issue 5, Pages 856-866

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2010.07.020

Keywords

Alzheimer's disease; AD; Magnetic resonance imaging; MRI; Imaging; Maternal history; Hippocampus; Atrophy; Biomarker; Hereditary; Genetic

Funding

  1. NIH [U01 AG024904, U54 RR021813]
  2. National Institute of Aging (NIA) [K23 AG026803, P50 AG16570]
  3. National Institute of Biomedical Imaging and Bioengineering (NIBIB) [EB01651]
  4. Foundation for the National Institutes of Health
  5. Pfizer Inc.
  6. Wyeth Research
  7. Bristol-Myers Squibb
  8. Eli Lilly and Company
  9. GlaxoSmithKline
  10. Merck Co. Inc.
  11. AstraZeneca AB
  12. Novartis Pharmaceuticals Corporation
  13. Alzheimer's Association
  14. Eisai Global Clinical Development
  15. Elan Corporation plc
  16. Forest Laboratories
  17. Institute for the Study of Aging (ISOA)
  18. Northern California Institute for Research and Education
  19. AFAR
  20. John A. Hartford Foundation
  21. Atlantic Philanthropies
  22. Starr Foundation
  23. Easton Consortium for Alzheimer Drug Discovery and Biomarker Development
  24. Turken Foundation
  25. NLM [LM05639]
  26. NCRR [RR019771, P41 RR013642]
  27. NIMH [R01 MH071940]

Ask authors/readers for more resources

We applied an automated hippocampal segmentation technique based on adaptive boosting (AdaBoost) to the 1.5 T magnetic resonance imaging (MRI) baseline and 1-year follow-up data of 243 subjects with mild cognitive impairment (MCI), 96 with Alzheimer's disease (AD), and 145 normal controls (NC) scanned as part of the Alzheimer's Disease Neuroimaging Initiative (ADNI). MCI subjects with positive maternal history of dementia had smaller hippocampal volumes at baseline and at follow-up, and greater 12-month atrophy rates than subjects with negative maternal history. Three-dimensional maps and volumetric multiple regression analyses demonstrated a significant effect of positive maternal history of dementia on hippocampal atrophy in MCI and AD after controlling for age, ApoE4 genotype, and paternal history of dementia, respectively. ApoE4 showed an independent effect on hippocampal atrophy in MCI and AD and in the pooled sample. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available